adverum
biotechnologies
participate
cantor
virtual
global
healthcare
conference
nasdaq
advm
redwood
city
globe
newswire
adverum
biotechnologies
nasdaq
advm
gene
therapy
company
targeting
unmet
medical
needs
ocular
rare
diseases
today
announced
company
present
cantor
virtual
global
healthcare
conference
tuesday
september
pm
pt
live
webcast
accessible
events
presentations
investors
section
company
website
archived
webcast
available
adverum
website
following
presentation
days
adverum
biotechnologies
adverum
biotechnologies
nasdaq
advm
gene
therapy
company
targeting
unmet
medical
needs
serious
ocular
rare
diseases
adverum
advancing
clinical
development
novel
gene
therapy
candidate
intravitreal
injection
treatment
patients
wet
macular
degeneration
diabetic
macular
edema
information
please
visit
investor
media
inquiries
investors
myesha
lacy
adverum
biotechnologies
mlacy
media
cherilyn
cecchini
lifesci
communications
ccecchini
